Pradaxa lawsuit

Pradaxa lawsuit: The resource center has learned that Pradaxa maker Boehringer Ingelheim is in phase one of clinical trials to test an antidote for Pradaxa internal bleeding. Pradaxa. Pradaxa, a direct thrombin inhibiting drug, prevents stroke by reducing the body’s ability to form blood clots. Pradaxa may be more likely to cause life threatening bleeding than other drugs used for this purpose. months later, Jackson, 75, a retired truck driver from the rural railroad community of Hohenwald.Jackson is one of millions of heart patients nationwide who have been prescribed Pradaxa.Pradaxa, by contrast, required fewer doctor check-ups and did not make patients eat selectively.The resource center contains information showing expert opinions about the risk for Pradaxa internal bleeding differ. pradaxa lawsuit